Healthgen Biotechnology Corp., founded in 2006, is a professional biopharmaceutical company. The company focuses on developing, manufacturing and marketing a series of environmental friendly and safe products by using the state-of-the-art platform called OryzHiExp, which can highly express proteins and small peptides in cereal crop endosperm.
Utilizng the OryzHiExp platform, Healthgen Biotechnology maximizes the innovative animal-free product development opportunities for clients and partners. It is cost-effective expression capability made it become a breakthrough expression platform.
Gained a number of patented technologies, Healthgen Biotechnology has achievements in developing and commercializing products, such as, rHSA (recombinant human serum albumin), rAAT (recombinant a1-anti-trypsin), rbFGF (recombinant basic fibroblast growth factor) and rLF (recombinant Lactoferrin).
With ten years experience in large-scaled production, Healthgen Biotechnology also can implement the industrial expression and products requirements.